A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said Monday. Despite the vaccine’s proven effectiveness, immunization rates remain low — about 40 percent of girls and 20 percent of boys between the ages of 13 and 17. Many doctors are pressing for primary care providers to strongly recommend the HPV vaccine in tandem with the other two that preteen children now typically receive. Click here for the Full Story published in the New York Times.
FluMist® pre-booking details are now available for the 2016-2017 flu season. Reservations must be made with your preferred authorized distributor by April 15, 2016. For complete details, please see the FluMist® Quadrivalent website.
Please remember CPP member practices can receive 5% off all orders of FluMist® throughout the entire 2016-2017 flu season, whether the doses are part of a pre-book or a part of subsequent reorders.
• For CPP members that have already submitted the MedImmune Declaration Form, you can place your FluMist® order with your distributor right now. You do not need to submit a new declaration form in 2016.
• For CPP members who want access to the CPP – MedImmune contract discount, please contact the CPP office at 614-722-2145 or email email@example.com to obtain a copy of the declaration form.
For any questions, please contact CPP at 614-722-2145 or firstname.lastname@example.org.